hormonreceptor-positive
Showing 1 - 25 of >10,000
Burn Out, Stress, Psychological, Well-Being, Psychological Trial in Hong Kong (App-based Positive Psychology Intervention (A&B),
Recruiting
- Burn Out
- +5 more
- App-based Positive Psychology Intervention (A&B)
- App-based Positive Psychology Intervention (C&D)
-
Hong Kong, Hong KongThe Hong Kong College of Anaesthesiologists
Nov 19, 2023
Breast Tumor Female Trial in Beijing (CDK4/6 inhibitor (Qilu),Trastuzumab (Hanquyou))
Recruiting
- Breast Neoplasm Female
- CDK4/6 inhibitor (Qilu),Trastuzumab (Hanquyou)
-
Beijing, Beijing, China
- +1 more
Jul 31, 2023
Anxiety Disorders, Public Speaking Fear Trial in Los Angeles (Exposure, Rehearsal)
Enrolling by invitation
- Anxiety Disorders
- Public Speaking Fear
- Exposure
- Rehearsal
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
Nov 9, 2023
Mental Health Issue Trial in Chicago, Urbana (culturally tailored mindfulness-positive psychological intervention)
Completed
- Mental Health Issue
- culturally tailored mindfulness-positive psychological intervention
-
Chicago, Illinois
- +2 more
Aug 24, 2023
Colon Cancer Trial in Beijing (Beyond complete mesocolic excision surgery)
Recruiting
- Colon Cancer
- Beyond complete mesocolic excision surgery
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
May 5, 2023
Advanced Breast Cancer, Objective Response Rate, Trastuzumab Emtansine Trial in Nanjing (Trastuzumab Emtansine (T-DM1))
Recruiting
- Advanced Breast Cancer
- +2 more
- Trastuzumab Emtansine (T-DM1)
-
Nanjing, Jiangsu, ChinaJiangSu Province Hospital/ The First Affiliated Hospital of Nanj
Nov 5, 2023
Asthma, COPD Trial in San Francisco (n-acetylcystine (NAC)+ albuterol, Hillrom-Volara System)
Recruiting
- Asthma
- COPD
- n-acetylcystine (NAC)+ albuterol
- Hillrom-Volara System
-
San Francisco, CaliforniaUCSF Airway Clinical Research Center
Nov 22, 2023
Positive End-expiratory Pressure, Hemodynamic Variable, Postoperative Atelectasis Trial in Tanta (Positive end-expiratory
Recruiting
- Positive End-expiratory Pressure
- +3 more
- Positive end-expiratory pressure 5 (PEEP 5)
- Individualized positive end-expiratory pressure (PEEPIND)
-
Tanta, El-Gharbia, EgyptTanta University
Nov 5, 2023
Metastatic Gastric Cancer, PD-L1 Gene Amplification, FGFR2 Amplification Trial in New York (Nivolumab, Capecitabine,
Recruiting
- Metastatic Gastric Cancer
- +2 more
- Nivolumab
- +2 more
-
New York, New YorkBureau for Cancer Research
May 10, 2023
Lumella-glycosylated Fibronectin for Diagnosis of Preeclampsia
Not yet recruiting
- Preeclampsia
- +2 more
- Lumella finger prick blood test
-
Croydon, Surrey, United KingdomCroydon University Hospital
Oct 11, 2023
MDD, Low Mood Trial in Annandale-on-Hudson (positive feedback)
Not yet recruiting
- Major Depressive Disorder
- Low Mood
- positive feedback
-
Annandale-on-Hudson, New YorkOnline research conducted through Bard College
Sep 5, 2023
Advanced Malignancies Trial in Beijing (1A46 Drug Substance)
Not yet recruiting
- Advanced Malignancies
- 1A46 Drug Substance
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Aug 4, 2023
Sentinel Lymph Node Biopsy in Initially Lymph Node-positive,
Completed
- Breast Cancer
- Sentinel Lymph Node
- Test cohort
-
Fuzhou, Fujian, ChinaChuan Wang
Nov 25, 2023
Relinking Diagnosed But Untreated HCV Patients Back Into Care.
Recruiting
- Hepatitis C Virus Infection
- Contact the patient
-
Brussel, BelgiumUZ Brussel
Aug 1, 2023
Breast Cancer. Real Clinical Practice in Russia
Recruiting
- Breast Cancer
- Neoadjuvant Endocrine Therapy
- Tamoxifen 20mg
- +4 more
-
Moscow, Russian FederationBlokhin's Russian Cancer Research Center
Apr 5, 2023
Gastrooesophageal Cancer Trial in United Kingdom (Trastuzumab deruxtecan)
Not yet recruiting
- Gastrooesophageal Cancer
- Trastuzumab deruxtecan
-
Southampton, Hampshire, United Kingdom
- +16 more
Jul 27, 2023
Safety and Efficacy of TCR-like CAR-T Trial in Nanjing (TCR-like CAR-T)
Recruiting
- Safety and Efficacy of TCR-like CAR-T
- TCR-like CAR-T
-
Nanjing, Jiangsu, ChinaZhongda hospital
Jul 26, 2023
Prostate Cancer Trial (3D Printed Models (3D printing facilities at GSTT), 3D Virtual Models (Innersight Labs))
Not yet recruiting
- Prostate Cancer
- 3D Printed Models (3D printing facilities at GSTT)
- 3D Virtual Models (Innersight Labs)
- (no location specified)
Aug 1, 2023
Well-being, Emotional and Behavioral Problems, Adolescents Trial in Sukkur (Well-Being Promotion Program)
Recruiting
- Well-being, Emotional and Behavioral Problems, Adolescents
- Well-Being Promotion Program
-
Sukkur, PakistanMadiha Arshad
Sep 29, 2023
Abbreviated Magnetic Resonance Imaging asScreening Tool for
Recruiting
- Hepatocellular Carcinoma
- MRI
-
Chandigarh, Punjab, IndiaPost Graduate Institute of Medical Education and Research
Feb 6, 2023
Nausea and Vomiting Trial in Sichuan (Heptaflurane combined Cyclophenol, Heptaflurane, Cyclophenol)
Enrolling by invitation
- Nausea and Vomiting
- Heptaflurane combined Cyclophenol
- +2 more
-
Sichuan, ChinaSichuan Provincial People's Hospital
Apr 19, 2023
Psychological Stress Trial in Merkez (Participants in the 8-week program)
Enrolling by invitation
- Psychological Stress
- Participants in the 8-week program
-
Merkez, Duzce, TurkeyDuzce University
Oct 10, 2023
NSCLC(NSCLC) Trial in Jinan (WX-0593 Tablets)
Not yet recruiting
- Non-Small Cell Lung Cancer(NSCLC)
- WX-0593 Tablets
-
Jinan, Shandong, ChinaShandong Cancer Hospital and Institute
Mar 1, 2023
Breast Cancer With Brain Metastases Trial in Wuhan (pyrotinib+capecitabine+bevacizumab)
Recruiting
- Breast Cancer With Brain Metastases
-
Wuhan, Hubei, ChinaTongji Hospital Affiliated of Tongji Medical College Huazhong Un
Nov 22, 2023
HER2-positive Gastric Cancer, Immunotherapy Trial in Shanghai (Disitamab Vedotin combined with fruquintinib and Tislelizumab)
Recruiting
- HER2-positive Gastric Cancer
- Immunotherapy
- Disitamab Vedotin combined with fruquintinib and Tislelizumab
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 8, 2023